LIGAND PHARMACEUTICALS INCORPORATED Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable of 1.07 million shares as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions · last filed 2026-02-27
- 2025-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.07M shares.
- 2024-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.23M shares.
- 2023-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.78M shares.
- 2022-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 1.56M shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable as first filed |
|---|---|---|
| 2025-12-31 | 1.07M shares 10-K · filed 2026-02-27 | |
| 2024-12-31 | 1.23M shares 10-K · filed 2025-02-28 | |
| 2023-12-31 | 1.78M shares 10-K · filed 2024-02-29 | |
| 2022-12-31 | 1.56M shares 10-K · filed 2023-02-28 | |
| 2014-12-31 | 1.13M shares 10-K · filed 2015-02-23 | 977.35K shares 10-K · filed 2014-12-01 |
| 2013-12-31 | 977.35K shares 10-K/A · filed 2014-12-12 | |
| 2012-12-31 | 816.90K shares 10-K · filed 2013-03-14 |